Sandra Sitar

3.7k total citations
5 papers, 483 citations indexed

About

Sandra Sitar is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Sandra Sitar has authored 5 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 2 papers in Epidemiology and 1 paper in Molecular Biology. Recurrent topics in Sandra Sitar's work include Influenza Virus Research Studies (2 papers), Respiratory viral infections research (2 papers) and Viral Infections and Vectors (2 papers). Sandra Sitar is often cited by papers focused on Influenza Virus Research Studies (2 papers), Respiratory viral infections research (2 papers) and Viral Infections and Vectors (2 papers). Sandra Sitar collaborates with scholars based in United States. Sandra Sitar's co-authors include Barney S. Graham, John R. Mascola, Karin Bok, Julie E. Ledgerwood, Gary J. Nabel, Richard A. Koup, Robert T. Bailer, Mary E. Enama, Zonghui Hu and Lee-Jah Chang and has published in prestigious journals such as The Lancet, Immunity and PLoS ONE.

In The Last Decade

Sandra Sitar

5 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Sitar United States	5	328	161	112	92	74	5	483
Mohammad Hassan Pouriayevali Iran	14	321 1.0×	112 0.7×	84 0.8×	60 0.7×	109 1.5×	51	497
Rima R. Sahay India	12	469 1.4×	113 0.7×	170 1.5×	30 0.3×	103 1.4×	39	567
Mandy Kader Kondé Guinea	13	263 0.8×	60 0.4×	173 1.5×	40 0.4×	42 0.6×	26	493
Anna M. Y. Yamamura Brazil	10	279 0.9×	320 2.0×	129 1.2×	30 0.3×	49 0.7×	14	436
Lee-Jah Chang United States	10	224 0.7×	167 1.0×	277 2.5×	95 1.0×	49 0.7×	17	534
Nivedita Gupta India	13	351 1.1×	134 0.8×	262 2.3×	22 0.2×	53 0.7×	41	564
Cheng-Lin Deng China	14	278 0.8×	260 1.6×	70 0.6×	68 0.7×	90 1.2×	17	466
Gabriel Defang United States	12	127 0.4×	75 0.5×	192 1.7×	66 0.7×	96 1.3×	19	403
Yuri Pervikov Switzerland	12	201 0.6×	81 0.5×	367 3.3×	109 1.2×	87 1.2×	15	537
Joanne Hiebert Canada	13	168 0.5×	84 0.5×	364 3.3×	69 0.8×	30 0.4×	39	468

Countries citing papers authored by Sandra Sitar

Since Specialization

Citations

This map shows the geographic impact of Sandra Sitar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Sitar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Sitar more than expected).

Fields of papers citing papers by Sandra Sitar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Sitar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Sitar. The network helps show where Sandra Sitar may publish in the future.

Co-authorship network of co-authors of Sandra Sitar

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Sitar. A scholar is included among the top collaborators of Sandra Sitar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Sitar. Sandra Sitar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Bok, Karin, Sandra Sitar, Barney S. Graham, & John R. Mascola. (2021). Accelerated COVID-19 vaccine development: milestones, lessons, and prospects. Immunity. 54(8). 1636–1651. 176 indexed citations

2.

Crank, Michelle C., Ingelise J. Gordon, Galina V. Yamshchikov, et al.. (2015). Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults. PLoS ONE. 10(4). e0123969–e0123969. 20 indexed citations

3.

Chang, Lee-Jah, Kimberly A. Dowd, Floreliz Mendoza, et al.. (2014). Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial. The Lancet. 384(9959). 2046–2052. 182 indexed citations

4.

Ledgerwood, Julie E., Kathryn L. Zephir, Zonghui Hu, et al.. (2013). Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect. The Journal of Infectious Diseases. 208(3). 418–422. 93 indexed citations

5.

Sarwar, Uzma, Sandra Sitar, & Julie E. Ledgerwood. (2010). Filovirus emergence and vaccine development: A perspective for health care practitioners in travel medicine. Travel Medicine and Infectious Disease. 9(3). 126–134. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact